Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Abstracts
Book Review
Case Report
Case Series
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:1 of 5
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:3 of 5
CMAS‡ - Pancreas - EUS-FNA Cytopathology (PSC guidelines) S1:4 of 5
CMAS‡ - Pancreas -Sampling Techniques for Cytopathology (PSC guidelines) S1:2 of 5
CMAS‡ - Pancreas- EUS-FNA Cytopathology (PSC guidelines) S1:5 of 5
Commentary
CytoJournal Monograph Related Review Series
CytoJournal Monograph Related Review Series (CMAS), Editorial
CytoJournal Monograph Related Review Series: Editorial
Cytojournal Quiz Case
Editorial
Erratum
Letter to Editor
Letter to the Editor
Letters to Editor
Methodology
Methodology Article
Methodology Articles
Original Article
Pap Smear Collection and Preparation: Key Points
Quiz Case
Research
Research Article
Review
Review Article
Systematic Review and Meta Analysis
View Point
View/Download PDF

Translate this page into:

Quiz Case
2021
:18;
15
doi:
10.25259/Cytojournal_27_2020

A huge vulval cyst with iliac lymph node enlargement – A unique presentation of a rare tumor

Department of Pathology, Government Medical College, Haldwani, Uttarakhand, India

*Corresponding author: Usha Joshi, Associate Professor, Department of Pathology, Government Medical College, Haldwani, Uttarakhand, India. ushajoshi@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Joshi K, Joshi U, Kaushik A. A huge vulval cyst with iliac lymph node enlargement – A unique presentation of a rare tumor. CytoJournal 2021;18:15.

A 32-year-old female presented with abdominal pain, right labial mass, and right iliac lymph node enlargement for 4 years, to the gynecology department. On examination, a fluctuant, polypoid mass involving the right labium majus was noted and clinical diagnosis of vulval cyst was made. Her MRI findings revealed a well-defined 10.0 × 10.0 × 5.0 cm right labial lesion with heterogeneous signal intensity. It revealed hyperintense signal with areas of hypointensity on T2 and predominantly hypointense on T1, without any calcifications. Another altered signal intensity lesion measuring 5 × 5 cm was seen along the right iliac vessels, suggestive of the right iliac lymphadenopathy. USG-guided fine-needle aspiration (FNA) of the right iliac lymph node was performed and slides were stained with PAP, H&E, and MGG [Figure 1].

FNAC of the right iliac lymph node (Arrowhead-plexiform vasculature, Arrow- lipoblast), PAP, ×100 (original).
Figure 1:
FNAC of the right iliac lymph node (Arrowhead-plexiform vasculature, Arrow- lipoblast), PAP, ×100 (original).

Q1 – WHAT IS YOUR INTERPRETATION?

  1. Angiomyxoma

  2. Myxofibrosarcoma

  3. Myxoid dermatofibrosarcoma protuberans

  4. Myxoid liposarcoma.

Question 1 answer – d-Myxoid liposarcoma.

BRIEF DISCUSSION

Smears made from FNA of the right iliac lymph node showed tissue fragments with myxoid matrix and plexiform vascular network [Figure 1: Arrowhead] surrounded by round to ovoid cells with mild atypia admixed with univacuolated to multivacuolated lipoblasts with scalloped nuclei [Figure 1: Arrow]. A diagnosis of low-grade myxoid liposarcoma (MLS) was made on FNAC. FNAC of the iliac lymph node was followed by removal of the right labial mass which was sent to pathology department for histopathological evaluation. The lesion was a well encapsulated, grayish-white to grayish-brown, lobular mass measuring 8.5 × 5.0 × 4.0 cm [Figure 2].

MRI well-defined 10.0 × 10.0 × 5.0 cm right vulval mass showing heterogeneous signal intensity, hypointense on T1 and hyperintense on T2.
Figure 2:
MRI well-defined 10.0 × 10.0 × 5.0 cm right vulval mass showing heterogeneous signal intensity, hypointense on T1 and hyperintense on T2.

Gross evaluation revealed solid, multilobulated cut surface with grayish-white, fleshy and gelatinous areas with foci of hemorrhage [Figure 3]. Representative sections were submitted for microscopic evaluation. H&E stained sections from labial mass showed nodular lesion with hypocellular and hypercellular areas. Hypocellular areas showed uniform round to oval-shaped cells admixed with variable number of univacuolated to multivacuolated lipoblasts embedded in prominent myxoid stroma, rich in arborizing chicken wire capillary vasculature [Figure 4].

Solid, grayish-brown multilobulated mass with grayish-white fleshy and gelatinous areas (original).
Figure 3:
Solid, grayish-brown multilobulated mass with grayish-white fleshy and gelatinous areas (original).
Hypocellular areas showing round cells admixed with lipoblasts (arrowhead) embedded in prominent myxoid stroma, rich in arborizing, plexiform capillary vasculature (arrow). (H and E, ×400) (original) Inset=lipoblast).
Figure 4:
Hypocellular areas showing round cells admixed with lipoblasts (arrowhead) embedded in prominent myxoid stroma, rich in arborizing, plexiform capillary vasculature (arrow). (H and E, ×400) (original) Inset=lipoblast).

Extensive grossing was done and then slides were stained with H&E. Sections from labial mass showed nodular lesion with hypocellular and hypercellular areas. Hypocellular areas show uniform round to oval-shaped cells admixed with variable number of univacuolated to multivacuolated lipoblasts embedded in prominent myxoid stroma, rich in arborizing chicken wire capillary vasculature [Figure 4]. Hypercellular areas showed predominantly sheets of round to ovoid cells (approximately 25%) with high nuclear cytoplasmic ratio and absent to scant amount of cytoplasm, favoring a diagnosis of high-grade MLS [Figure 5].

Hypercellular areas showing predominantly sheets of round to ovoid cells. (H and E, ×100) (original).
Figure 5:
Hypercellular areas showing predominantly sheets of round to ovoid cells. (H and E, ×100) (original).

ADDITIONAL QUIZ QUESTIONS

Q2 – Plexiform blood vessels are frequently seen in all except

  1. MLS

  2. Superficial angiomyxoma

  3. Lipoblastoma

  4. Myxofibrosarcoma.

Q3 – Unimultivacuolated cells with scalloping of nuclei are the feature of

  1. Foamy macrophage

  2. Pseudolipoblast

  3. Lipoblast

  4. Adipocyte.

Q4 – Most common translocation involving MLS is?

  1. t(12;16)(q13;p11)

  2. t(7;16)(q33;p11)

  3. t(17;22)(q21.3;q13.1)

  4. t(11;12)(q23;q15).

ANSWERS TO ADDITIONAL QUESTIONS

Q2 (d); Q3 (c); Q4 (a).

Q2 (d) – Plexiform vessels are thin branching vessels usually seen in MLS, superficial angiomyxoma, and lipoblastoma. Myxofibrosarcomas, meanwhile, show thick walled, curvilinear vessels with perivascular alignment of tumor cells.

Q3 (c) – Criteria for diagnostic lipoblast include – hyperchromatic, indented or sharply scalloped nucleus with lipid-rich droplets in cytoplasm, and an appropriate histological background. Multivacuolated cells distended with hyaluronic acid (pseudolipoblast) can be seen in myxofibrosarcoma.

Q4 (a) – The entire range of myxoid/round cell liposarcoma is genetically tied to recurrent rearrangement of DDIT3 that partners with FUS in >95% of cases with a resulting FUSDDIT3 fusion [t(12;16) (q13;p11)] or partners with EWSR1 in the remaining cases with a resulting EWSR1-DDIT3 fusion [t(12;22) (q13;q12)]. Identification of either the FUS-DDIT3 or EWSR1-DDIT3 transcript is considered both highly sensitive and specific for myxoid/round cell liposarcoma, allowing its distinction from morphologically similar neoplasms.

BRIEF REVIEW OF TOPIC

Vulvar sarcomas account for only 1–3% of all vulvar malignancies and the most frequent primary vulvar sarcoma is leiomyosarcoma.[1,2] MLS of vulva is very rare and only seven cases are reported in literature till date, to the best of our knowledge [Table 1].[3-8] MLS is the second most common subtype of liposarcoma harboring translocation (12;16) (q13;p11) which creates a chimeric gene FUS-DDIT3 and it encompasses a spectrum of tumors defined by their degree of lipoblastic differentiation. It is divided into low-grade and high-grade MLS according to the WHO classification proposed in 2013. At one end of the spectrum is low-grade MLS associated with favorable prognosis and, on the other end, is, high-grade MLS, defined as having ≥5% round cell component, considered more aggressive tumor which tends to metastasize.

Table 1: Clinical profile of seven cases of MLS of vulva (original).
Study Age (years) Site Duration Clinical diagnosis Maximum size (cm) Management Outcome
Brooks and LiVolsi[3] 15 Vulvar perineum, recurred on the left posterior medial thigh 20 months Soft-tissue sarcoma 18 Wide excision; local recurrence as round cell/high-grade myxoid liposarcoma 20 months later treated by chemotherapy DOD*
Donnellan and Moodley[4] 26 Left labium majus et minor 4 years Bartholin cyst 10 Local excision followed by reexcision NED+ 9 m
Wu and Tarn[5] 45 Right labium majus 72 months Lipoma 7 Local excision; reexcision of 6 cm recurrence 16 months later NED, 28 m
Schoolmeester et al.[6] 34 Left vulval mass 11 months Unknown 11.7 Local excision NED, 28 m
Baek et al.[7] 33 Bilateral perineum 4 months Unknown Wide excision NED, 2 yr
Kwak et al.[8] 37 Bilateral vulval mass 3 weeks Unknown 20 and 15 Local excision with radiotherapy NED, 44 m
Present case 32 Right labium majus 4 years Cyst 8.5 Wide excision NED, 6 m
DOD: Died of disease, +NED: No evidence of disease

MLS of vulva can be mistaken clinically as benign because of their rare location and presentation, which can lead to delayed treatment.[9,10] Like in our case, a clinical diagnosis of vulval cyst was made and patient presented with iliac lymph node metastasis which was reported as low-grade MLS. However, on histopathology of labial mass, we encountered the round cell component as well, thus rendering it as high-grade MLS. Sometimes in hypercellular variant, stroma is less myxoid and capillary network is less prominent leading to erroneous diagnosis of round cell tumor on FNAC. Hence, there is a need for extensive sampling.

Histologically, MLS can be confused with other myxoid tumors more common in the vulva such as aggressive angiomyxomas, botryoid embryonal rhabdomyosarcoma, myxoid dermatofibrosarcoma protuberans, myxofibrosarcoma, and myxoid leiomyosarcoma [Table 2].

Table 2: Differential diagnosis of myxoid lesions of vulva.
Differential diagnosis Age Location Gross Microscopy IHC Genetics
Growth pattern Cellularity Morphology LB Blood vessels Background Mitotic activity
Angio
myxoma
Reproductive age (30 years) Superficial and deep Polypoidal, partly circumscribed
cut surface is homogenously gelatinous
Infiltrative Low Spindle and stellate cells with small round hyperchromatic nuclei -nt Small thin walled to large hyalinized blood vessels Myxoid with fine collagen fibrils Rare absent CD34
Vimentin
ER
PR
t(12;21)
(q15;q21.1)
Botryoid RMS Children (<10 years) Mucosa lined hollow organs Polypoidal with clusters of small sessile or pedunculated nodules Polypoidal Mode-rate Subepithelial condensation of tumor cells (cambium layer) comprising of primitive small round cells, stellate cells and rhabdomyoblast -nt - Myxoid Low to mode rate Vimentin
MyoD1
Myogenin
Loss of heterozygosity chromosome 11p15.5
Myxoid DFSP Young-middle-aged adults Superficial Multinodular cutaneous masses, gray-white cut surface with gelatinous areas Diffuse infiltrative Mode-rate Uniform spindle cells with plump elongate nuclei arranged in storiform pattern -nt Prominent thin-walled vessels Myxoid Low to mode
rate
CD34 t(17;22)
(q21.3;q13.1)
(COL1A1-PDGFB)
Myxoid
leiomyo
sarcoma
Middle to older Deep soft tissue Well-demarcated
cut surface is fleshy white-gray mass with whorled app & foci of gelatinous changes
Ill defined Mode-rate Elongated spindle cells with blunt-ended nuclei arranged in long dissecting fascicles -nt Not seen Myxoid Low SMA, CALDESMON Complex with genetic instability
MFS Elderly (60–80 yrs) Superficial and deep Multiple gelatinous nodules (superficial)
Single mass with infiltrative margin (deep)
cut surface is variably gelatinous
Multi
nodular
Moderate Plump, spindle or stellate cells having large atypical hyperchromatic nucleus Pseudolipo
blast
Curvilinear, elongated blood vessels with perivascular condensation of tumor cells Myxoid High MSA, SMA Complex karyotype
MLS Young adults Deep soft tissue Well-circumscribed, multinodular
cut surface is gelatinous to fleshy
Nodular Mode-rate Mixture of uniform round-oval cells and bland fusiform cells +nt Plexiform, branching Myxoid Rare Vimentin
S100
t(12;16)
(q13;p11)
(FUS-DDIT3)

LB: Lipoblast, RMS: Rhabdomyosarcoma, DFSP: Dermatofibrosarcoma protuberans, MFS: Myxofibrosarcoma, MLS: Myxoid liposarcoma, -nt: Absent, +nt: Present

SUMMARY

Vulvar MLS is an extremely rare case reported in the literature. The present case marks the seventh reporting of vulval myxoid/ round cell liposarcoma and the first one presenting with iliac lymph node metastasis. Both pathologists and clinicians should be aware of the occurrence of this entity in vulval region to ensure the correct diagnosis and appropriate management of the patient with this potentially curable neoplasm.

COMPETING INTEREST STATEMENT BY ALL AUTHORS

The authors declare that they have no competing interests.

AUTHORSHIP STATEMENT BY ALL AUTHORS

All authors certify that we have actively participated in the conception, design, defining intellectual content and preparation and editing of manuscript.

ETHICS STATEMENT BY ALL AUTHORS

This was a retrospective analysis of the data and all the procedures were done after obtaining informed consents from patients.

LIST OF ABBREVIATIONS (In alphabetic order)

DFSP – Dermatofibrosarcoma protuberans

FNA – Fine needle aspiration

FNAC – Fine needle aspiration cytology

LB – Lipoblast

MLS – Myxoid liposarcoma

MFS – Myxofibrosarcoma

RMS – Rhabdomyosarcoma.

EDITORIAL/PEER-REVIEW STATEMENT

To ensure the integrity and highest quality of CytoJournal publications, the review process of this manuscript was conducted under a double-blind model (the authors are blinded for reviewers and vice versa) through automatic online system.

References

  1. , , , , . Radiotherapy for liposarcoma of the vulva. Gynecol Oncol. 2000;79:315-7.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , . Sarcoma of the vulva-report of 12 patients. Obstet Gynecol. 1971;38:180-4.
    [Google Scholar]
  3. , . Liposarcoma presenting on the vulva. Am J Obstet Gynecol. 1987;156:73-5.
    [CrossRef] [Google Scholar]
  4. , . Vulval myxoid liposarcoma. Int J Gynecol Cancer. 2001;11:3212.
    [CrossRef] [Google Scholar]
  5. , . Vulvar myxoid liposarcoma. Taiwan J Obstet Gynecol. 2007;46:293-4.
    [CrossRef] [Google Scholar]
  6. , , , . Vulvar myxoid liposarcoma and well differentiated liposarcoma with molecular cytogenetic confirmation: Case reports with review of malignant lipomatous tumors of the vulva. Int J Gynecol Pathol. 2015;34:390-5.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . A case of liposarcoma of the perineum. Korean J Obstet Gynecol. 2007;50:932-5.
    [Google Scholar]
  8. , , , . Unusual bilateral vulvar liposarcoma. Obstet Gynecol Sci. 2014;57:549-52.
    [CrossRef] [PubMed] [Google Scholar]
  9. , . Vulval liposarcoma. Arch Gynecol. 1987;240:63-6.
    [CrossRef] [PubMed] [Google Scholar]
  10. , . Liposarcoma (atypical lipomatous tumors) of the vulva: A clinicopathologic study of six cases. Int J Gynecol Pathol. 1998;17:17-23.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections